Fizazi, A. et al. 2024. High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors. Acta Dermato-Venereologica. 104, (Nov. 2024), adv40913. DOI:https://doi.org/10.2340/actadv.v104.40913.